US stock options flow analysis and unusual options activity tracking to identify smart money positions in the market. Our options intelligence reveals hidden bets and sentiment indicators that often precede major price moves.
Xencor Inc. (XNCR), a clinical-stage biopharmaceutical company focused on developing engineered protein therapies for autoimmune disease and oncology indications, is currently trading at $12.74 per share, marking a 0.86% decline in recent trading sessions. No recent earnings data is available for the firm as of the current date, so near-term price action has been driven primarily by broader market sentiment, biotech sector trends, and technical trading patterns rather than company-specific funda
Xencor (XNCR) Stock Optional Convertible (Wavering) 2026-04-23 - Hot Momentum Watchlist
XNCR - Stock Analysis
3958 Comments
1050 Likes
1
Dajae
Elite Member
2 hours ago
Helps contextualize recent market activity.
👍 99
Reply
2
Yahoshua
Engaged Reader
5 hours ago
I blinked and suddenly agreed.
👍 296
Reply
3
Drais
Trusted Reader
1 day ago
If only I had seen it earlier today.
👍 146
Reply
4
Florentine
Experienced Member
1 day ago
I understood enough to pause.
👍 176
Reply
5
Sifra
Loyal User
2 days ago
This feels like it knows me personally.
👍 253
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.